Friday, November 22, 2024
11/22/2024
Muscle atrophy (or wasting) is defined by reduced myofiber size and number, which increases morbidity and mortality and decreases quality of life. One of the mechanisms of muscle atrophy is the loss of proteostatic balance. When protein degradation exceeds synthesis, protein content is decreased to reduce myofiber size and muscle mass. How the balance between protein synthesis and degradation is disturbed in diseased and aged skeletal muscle in unknown. Mitochondrial dysfunction plays an important role in skeletal muscle atrophy under many disease conditions and during normative aging, with the underlying mechanism remaining poorly understood. Perturbations in oxidative phosphorylation and the subsequent increase in reactive oxygen species production, collectively termed “bioenergetic defects”, have been proposed to drive muscle loss. However, accumulating evidence suggests that substantial levels of bioenergetic deficiency and oxidative stress are insufficient to cause muscle wasting. Therefore, if mitochondrial dysfunction does indeed result in muscle loss, it may involve bioenergetically independent factors. The Chen lab recently found that various forms of mitochondrial damage can reduce mitochondrial protein import. This causes proteostatic stress in the cytosol, termed mitochondrial Precursor Overaccumulation Stress (mPOS), followed by global remodeling of proteostasis. We recently generated a transgenic mouse line that moderately overexpresses the mitochondrial inner membrane protein, Ant1. We found that Ant1-induced mitochondrial protein import stress causes progressive muscle atrophy, accompanied by reduction of mitochondrial respiration. However, whether muscle atrophy is caused by bioenergetic deficiency or bioenergetic-independent stressors remains unknown. Interestingly, RNA-seq analysis revealed a robust activation of the integrated stress response (ISR), which in turn represses global protein synthesis and activates autophagy. ISR activation is commonly found in tissues derived from patients with mitochondrial disease. Using this unique mouse model, we propose to determine the molecular mechanisms of mitochondria-induced muscle atrophy and ISR activation. In Aim 1, we will determine the mechanism by which mitochondrial protein import stress induces muscle wasting. In Aim 2, we will determine whether ISR activation protects skeletal muscle from myofiber death and myopathy in the setting of mPOS. The long-term goal of this project is to understand how bioenergetics-independent mitochondrial stress signaling promotes chronic muscle wasting in normative and non-normative aging. The results of this application may help establish a bioenergetics-independent pathway for treating mitochondria-induced muscle disease and possibly sarcopenia.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
